A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection
- 1 July 1996
- journal article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 3 (4) , 211-215
- https://doi.org/10.1111/j.1365-2893.1996.tb00098.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovoJournal of Medical Virology, 1994
- Phase II trial of lamivudine for chronic hepatitis BHepatology, 1993
- A cell culture assay for compounds which inhibit hepatitis B virus replicationAntiviral Research, 1991
- Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type BJournal of Hepatology, 1990
- Which Patients With Chronic Hepatitis B Virus Infection Will Respond to α–Interferon Therapy? A Statistical Analysis of Predictive FactorsHepatology, 1989
- PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDRENThe Lancet, 1987
- The detection of hbv‐dna in serum by molecular hybridisation: A more sensitive method for the detection of complete hbv particlesJournal of Medical Virology, 1982
- ACYCLOVIR INHIBITS HEPATITIS B VIRUS REPLICATION IN MANThe Lancet, 1982
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUSThe Lancet, 1981